Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts

NCT02246738 · clinicaltrials.gov ↗

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma of the Bladder

Interventions

OTHER: Blood Collection

Sponsor

Abramson Cancer Center at Penn Medicine